Biblio

Author Title [ Type

] Year

Filters: Author is Park, Sophie [Clear All Filters]

Journal Article

Peterlin P, Le Bris Y, Turlure P, Chevallier P, Ménard A, Gourin M-P, Dumas P-Y, Thépot S, Berceanu A, Park S, et al. CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study. Lancet Haematol. 2023.

Itzykson R, Santini V, Thépot S, Ades L, Chaffaut C, Giagounidis A, Morabito M, Droin N, Lübbert M, Sapena R, et al. Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network. J Clin Oncol. 2022:JCO2200437.

Emadali A, Hoghoughi N, Duley S, Hajmirza A, Verhoeyen E, Cosset F-L, Bertrand P, Roumier C, Roggy A, Suchaud-Martin C, et al. Haploinsufficiency for NR3C1, the gene encoding the glucocorticoid receptor, in blastic plasmacytoid dendritic cell neoplasms. Blood. 2016.

Brault J, Vigne B, Meunier M, Beaumel S, Mollin M, Park S, Stasia MJosé. NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells. Free Radic Biol Med. 2019.

Koreth J, Pidala J, Perez WS, H Deeg J, Garcia-Manero G, Malcovati L, Cazzola M, Park S, Itzykson R, Ades L, et al. Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis. J Clin Oncol. 2013.